Biotech Biotech November 11, 2024 STAT Plus: Schizophrenia drug AbbVie picked up in $9 billion acquisition fails in key trials
The Readout The Readout November 11, 2024 Risk of aspiration during surgery added to GLP-1 drug labels
Biotech Biotech November 9, 2024 STAT Plus: Biotech analyst Brian Skorney and CEO Daphne Zohar weigh in on election results